Surescripts Acquires ActiveRADAR to Offer Therapeutic Alternatives for Prescriptions

Surescripts, the nation’s leading health information network, acquired ActiveRADAR, a clinical intelligence company that identifies therapeutic alternatives for prescriptions. “We are always looking for ways to broaden our impact on patients and the people who care for them,” explained Frank Harvey, Chief Executive Officer at Surescripts. “Our acquisition of ActiveRADAR underscores our commitment to optimizing our network solutions with even more comprehensive clinical and cost data available at the point of prescribing. Together, we can make it simpler and faster to get patients started on the best medication for them.” ActiveRADAR (formerly known as RxTE Health) offers evidence-based, formulary-specific, and medically accepted use-specific therapeutic alternatives, along with corresponding dosage strengths, quantities, and plan-specific patient and health plan costs. ActiveRADAR’s Clinical Catalogue covers more than 165 therapeutic categories, including more than 30 specialty drug categories and more than 33,000 drug pairs, as well as both clinical and economic value on medication alternatives, and has been shown to reduce costs for employers and employees by 15 to 20%. “We are very pleased to have reached this agreement which will allow ActiveRADAR to have a direct impact on improving medication adherence as well as patient and provider engagement,” said Dave Teckman, former Chief Executive Officer at ActiveRADAR. “Our analytical processes target and...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT ActiveRADAR Dave Teckman Dr. Lynne Nowak Frank Harvey Health IT Acquisitions Healthcare M&A RxTE Health SureScripts Source Type: blogs